Clinical Trials Browser

Phase 2 × INDUSTRY × codrituzumab × Clear all

NCT01507168 2020-04-03

A Study of GC33 (RO5137382) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

Phase 2 Completed

Gastrointestinal

Carcinoma, Hepatocellular